Publications

The publication of research results is a fundamental requirement for improving treatment concepts across the board. iOMEDICO supports the international guidelines on transparency and publication of medical research results.

We regularly present our data at national and international conferences. Our publications appear in scientifically renowned, international journals. Authors are principal investigators, investigators with a high number of participating patients, and iOMEDICO scientists.

TITEL
STUDIE
JAHR
Plasma proteins characterize second-line therapy response in progressive renal cell carcinoma.

Hölters, S., Bergmann, L., Grünwald, V., Keilholz, U., Ohlmann, C., Staehler, M., Schmerler, D., Junker, K., 2014.

AACR (San Diego) 901.

Abstract

Indikation: Urogenital Tumors, Urogenitale Tumore / Veranstaltung: AACR / Journal: -
MARC-2
2014
Wirksamkeit erneuter Anti-HER2-Therapie mit Herceptin® in der klinischen Routine bei erstem Rezidiv und/oder erster Metastasierung des HER2-positiven Mammakarzinoms – 4. Interimanalyse der nichtinterventionellen Studie (NIS) ML21589.

Hanker, L., Hitschold, T., Grafe, A., Förster, F., Schröder, J., Janssen, J., Reichert, D., Wohlfarth, T., Greinemann, J., Hesse, T., 2014.

Senologie 11(02), A50(P027). doi:10.1055/s-0034-1375409

Abstract

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: Senologie Kongress / Journal: Senologie
Herceptin-NIS
2014
Efficacy of anti-HER2 ReTherapy with Herceptin® at first relapse and/or first occurrence of metastases of HER2-positive breast cancer in clinical routine – 4th interim analysis of the non-interventional study (NIS) ML21589.

Hanker, L., Hitschold, T., Grafe, A., Förster, F., Schröder, J., Janssen, J., Reichert, D., Wohlfarth, T., Greinemann, J., Hesse, T., 2014.

Ann Oncol 25(suppl4), iv131 (400P). doi:10.1093/annonc/mdu329.49

Abstract

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: ESMO / Journal: Annals of Oncology
Herceptin-NIS
2014
A nonrandomized, phase IV trial of FOLFIRI and cetuximab in first-line treatment of metastatic colorectal cancer receiving a predefined skin care and skin prophylaxis aiming to prevent a skin rash.

Goehler, T., Woerns, M.A., Hebart, H.F., Heike, M., Neise, M., Rudi, J., Geer, T., Dingeldein, G., Lang, C., Ehscheidt, P., Flohr, T., Josten, K.M., Karthaus, M., Schmittel, A.H., Wierecky, J., Galle, P.R., Dhensaw, C., Moehler, M.H., Schimanski, C.C., 2014.

J Clin Oncol 32 (suppl; abstr e20724). doi: 10.1200/jco.2014.32.15_suppl.e20724

Abstract

Indikation: Colorectal Cancer, Kolorektalkarzinom / Veranstaltung: ASCO / Journal: Journal of Clinical Oncology
DERMATUX
2014
Effectiveness of 1st-line treatment options in mRCC – a German RCC-Registry evaluation.

Goebell, P.J., Müller, L., Lück, A., Overkamp, F., Vogt, M., Marschner, N., 2014.

J Clin Oncol, ASCO GU, San Francisco 32, (suppl.4; abstr 429). doi:10.1200/jco.2014.32.4_suppl.429

Abstract

Download

Indikation: Urogenital Tumors, Urogenitale Tumore / Veranstaltung: GCS (ASCO) / Journal: Journal of Clinical Oncology
TNK
2014
Behandlungsrealität von Patienten mit metastasiertem Nierenzellkarzinom in Deutschland – Daten aus dem RCC-Register.

Goebell, P.-J., Müller, L., Hübner, A., Lück, A., Koska, M., Marschner, N., 2014.

oral presentation, DGU.

Indikation: Urogenital Tumors, Urogenitale Tumore / Veranstaltung: DGU / Journal: -
TNK
2014
A cross-sectional investigation of fatigue in advanced renal cell carcinoma treatment: Results from the FAMOUS study.

Goebell, P., Münch, A., Müller, L., Hurtz, H.-J., Koska, M., Busies, S., Marschner, N., 2014.

Urol Oncol 32, 362–370. doi:10.1016/j.urolonc.2013.09.009

Abstract

Indikation: Urogenital Tumors, Urogenitale Tumore / Veranstaltung: - / Journal: Urologic Oncology
TNK
2014
Behandlungsrealität von Patienten mit metastasiertem Nierenzellkarzinom in Deutschland – Daten aus dem RCC-Register.

Eder E, Müller L, Hübner A, Koska M, Marschner N, Goebell P-J, 2014.

Oral presentation at Gemeinsame Tagung BUV/OEGU. 2014;(FV17).

Indikation: Urogenital Tumors, Urogenitale Tumore / Veranstaltung: Bayrische Urologenvereinigung / Journal: -
TNK
2014
Bendamustine-based first line therapy in chronic lymphocytic leukemia (CLL) in routine clinical practice: Interim analysis of the German non-interventional study Be-CeLL1st.

Bruch, H.-R., Aldaoud, A., Klausmann, M., Hansen, R., Losem, C., Frank, M., Straßl, L., Ruffert, K., 2014.

Haematologica 99 (suppl 1) (PB1504).

Abstract

Indikation: Haemoblastoma, Hämoblastosen / Veranstaltung: EHA / Journal: Haematologica
Be-Cell-1st
2014
Chemotherapy, targeted therapy and anti-hormonal therapy of elderly patients with breast cancer – data from the SENORA project.

Zahn, M.-O., Tesch, H., Köhler, A., Fietz, T., Münz, M., Kruggel, L., Jänicke, M., Marscher, N., 2014.

Oncol Res Treat 37 (suppl 5)(V374), 112. doi:10.1159/000368945

Abstract

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: DGHO / Journal: Oncology Research and Treatment
TMK
2014